SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

CBLL

Ceribell, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 2h ago
Insider cluster: 2 insiders, $309K total
Actionable Insight • Neutral

The dollar amount is trivial relative to market cap, and one sale was pre-planned. No signal of deteriorating fundamentals given the recent revenue beat and raised guidance. Monitor next quarter for any change in insider selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$26.42
T+0 close · Nov 13, 2026 · via day close
Latest settled
−1.70%
T+1 · $25.97
Vs SPY
−0.69%
α at T+1
Next horizon
T+5
in 5d
  1. T+0 · Nov 16 $26.42entry
  2. T+1 · 13h ago −1.70%α −0.69% · $25.97
  3. T+5 · in 5d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors sold a total of $309K in open-market sales within a week of Ceribell's Q3 earnings. Director Burke's sale was under a 10b5-1 plan; Director Taylor's was not. The total is 0.03% of market cap, well below the 0.1% materiality threshold, making this a routine cluster.

Key Financial Metrics

Direction
selling
Total Value
$309.0K
Insiders
2

Key Facts

  • Two directors sold shares in the week after Q3 2026 earnings
  • Total open-market sales: $309K (0.03% of $1.1B market cap)
  • Director Burke's sale was under a 10b5-1 plan; Director Taylor's was not
  • Q3 revenue of $29.3M (+30% YoY) slightly beat consensus; GAAP EPS of -$0.55 missed consensus of -$0.52
  • Full-year 2026 revenue guidance raised to $115M-$117M

Financial Impact

Total insider sales of $309K, representing 0.03% of market cap

Risk Factors

  • Insider sales are small and routine; no material risk identified
  • GAAP EPS miss may pressure near-term sentiment but was already disclosed in the Q3 release

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CBLL-1794611466570

Track record

39 reports on CBLL

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+1. Best: +17.06% at T+60 after the Feb 23, 2026 report. 8 of 10 went positive at some point.

Filters
  1. Nov 17, 2026today Insider Cluster Neutral 3/10 Entry $26.09 Now $26.42 +1.26% settles Nov 19
  2. Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $26.42 Now $26.42 +0.00% settles Nov 18
  3. Nov 16, 20261d ago 144 Neutral 2/10 Entry $26.42 to $25.97 Now $26.42 +0.00% ▼ −1.70% −0.69% vs SPY
  4. Nov 13, 20264d ago Insider Cluster Neutral 2/10 Viewing Entry $26.42 to $25.97 Now $26.42 +0.00% ▼ −1.70% −0.69% vs SPY
  5. Nov 12, 20265d ago 144 Neutral 2/10 Entry $26.14 to $26.42 Now $26.42 +1.07% ▲ +1.07% +2.98% vs SPY
  6. Nov 10, 20267d ago Insider Cluster Neutral 2/10 Entry $27.80 to $26.35 Now $26.42 −4.96% ▼ −5.22% −4.86% vs SPY
  7. Nov 9, 20268d ago 144 Neutral 2/10 Entry $27.60 to $27.48 Now $26.42 −4.28% ▼ −0.43% −0.07% vs SPY
  8. Nov 3, 202614d ago 8-K Neutral 5/10 No price data
  9. Nov 3, 202614d ago Press Release Neutral 5/10 Entry $27.39 to $26.01 Now $26.42 −3.54% ▼ −5.04% −0.63% vs SPY
  10. Nov 2, 202615d ago 144 Neutral 2/10 Entry $26.96 to $28.27 Now $26.42 −2.00% ▲ +4.86% +4.56% vs SPY
Showing 10 of 39

US Market Status

Market Closed · Opens Thu (13h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026